Velan Capital Investment Management LP: 13F holdings
CIK 18488092026Q2
| Positions | 50 |
|---|---|
| Reported value | $164.2m |
| Filed | 2026-08-14 |
Top 10 holdings
| Security | Shares | Value | Weight |
|---|---|---|---|
| PRAX PRAXIS PRECISION MEDICINES I | 88,781 | $29.7m | 18.1% |
| MAPLIGHT THERAPEUTICS INC | 492,893 | $17.7m | 10.8% |
| SUTRO BIOPHARMA INC | 512,160 | $17.0m | 10.4% |
| IMMIX BIOPHARMA INC | 1,085,000 | $11.2m | 6.8% |
| PROTARA THERAPEUTICS INC | 2,844,652 | $10.9m | 6.6% |
| ABIVAX SA | 65,630 | $8.7m | 5.3% |
| TENAX THERAPEUTICS INC | 549,985 | $8.0m | 4.9% |
| ANTERIS TECHNOLOGIES GLOBAL | 700,000 | $6.9m | 4.2% |
| EDESA BIOTECH INC | 827,500 | $6.7m | 4.1% |
| EVOMMUNE INC | 451,255 | $6.0m | 3.7% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1848809")Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.